The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase‐positive non‐small cell lung cancer

Abstract Background Despite recent advances in treating non‐small cell lung cancer (NSCLC) with immune checkpoint inhibitors (ICIs), their role in ALK‐positive NSCLC patients is unclear. We investigated the efficacy of ICIs in patients with ALK‐positive NSCLC. Methods Between 2011 and 2018, a total...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ja Yoon Heo, Changhee Park, Bhumsuk Keam, Chan‐Young Ock, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Dae Seog Heo
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2019-11-01
Colecção:Thoracic Cancer
Assuntos:
Anaplastic lymphoma kinase
immune checkpoint inhibitors
non‐small cell lung cancer
Acesso em linha:https://doi.org/10.1111/1759-7714.13195
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados